Karmacharya P, Chakradhar R, Ogdie A. The epidemiology of psoriatic arthritis: a literature review. Best Pract Res Clin Rheumatol. 2021;35(2):101692. https://doi.org/10.1016/j.berh.2021.101692.

Article  PubMed  Google Scholar 

Costa L, Ramonda R, Ortolan A, Favero M, Foti R, Visalli E, et al. Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment. Clin Rheumatol. 2019;38:2355–62. https://doi.org/10.1007/s10067-019-04663-6.

Article  PubMed  Google Scholar 

Toussirot E, Gallais-Sérézal I, Aubin F. The cardiometabolic conditions of psoriatic disease. Front Immunol. 2022. https://doi.org/10.3389/fimmu.2022.970371.

Article  PubMed  PubMed Central  Google Scholar 

Puig L. Cardiometabolic comorbidities in psoriasis and psoriatic arthritis. Int J Mol Sci. 2017;19(1):58. https://doi.org/10.3390/ijms19010058.

Article  PubMed  PubMed Central  Google Scholar 

Karmacharya P, Ogdie A, Eder L. Psoriatic arthritis and the association with cardiometabolic disease: a narrative review. Ther Adv Musculoskelet Dis. 2021. https://doi.org/10.1177/1759720X21998279.

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization Western Pacific Region (2016) The Asia-Pacific perspective: redefining obesity and its treatment [Internet] Geneva: World Health Organization; 2000

Dikbas O, Tosun M, Bes C, Tonuk SB, Aksehirli OY, Soy M. Serum levels of visfatin, resistin and adiponectin in patients with psoriatic arthritis and associations with disease severity. Int J Rheum Dis. 2016;19(7):672–7. https://doi.org/10.1111/1756-185X.12444.

Article  PubMed  Google Scholar 

Toussirot Ã, Aubin F, Dumoulin G. Relationships between adipose tissue and psoriasis, with or without arthritis. Front Immunol. 2014. https://doi.org/10.3389/fimmu.2014.00368.

Article  PubMed  PubMed Central  Google Scholar 

Lubrano E, Scriffignano S, Azuaga AB, Ramirez J, Cañete JD, Perrotta FM. Impact of comorbidities on disease activity, patient global assessment, and function in psoriatic arthritis: a cross-sectional study. Rheumatol Ther. 2020;7:825–36. https://doi.org/10.1007/s40744-020-00229-0.

Article  PubMed  PubMed Central  Google Scholar 

Singh S, Facciorusso A, Singh AG, VandeCasteele N, Zarrinpar A, Prokop LJ, et al. Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: a systematic review and meta-analysis. PLoS ONE. 2018;13:e0195123. https://doi.org/10.1371/journal.pone.0195123.

Article  PubMed  PubMed Central  Google Scholar 

Wang J-Y, Wang Q-W, Yang X-Y, Yang W, Li D-R, Jin J-Y, et al. GLP−1 receptor agonists for the treatment of obesity: role as a promising approach. Front Endocrinol (Lausanne). 2023. https://doi.org/10.3389/fendo.2023.1085799.

Article  PubMed  PubMed Central  Google Scholar 

Popoviciu M-S, Păduraru L, Yahya G, Metwally K, Cavalu S. Emerging role of GLP-1 agonists in obesity: a comprehensive review of randomised controlled trials. Int J Mol Sci. 2023;24(13):10449. https://doi.org/10.3390/ijms241310449.

Article  PubMed  PubMed Central  Google Scholar 

Chen J, Mei A, Wei Y, Li C, Qian H, Min X, et al. GLP-1 receptor agonist as a modulator of innate immunity. Front Immunol. 2022. https://doi.org/10.3389/fimmu.2022.997578.

Article  PubMed  PubMed Central  Google Scholar 

Ferguson LD, Siebert S, McInnes IB, Sattar N. Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions. Nat Rev Rheumatol. 2019;15:461–74. https://doi.org/10.1038/s41584-019-0256-0.

Article  PubMed  Google Scholar 

Boehncke W-H, Boehncke S, Tobin A-M, Kirby B. The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol. 2011;20:303–7. https://doi.org/10.1111/j.1600-0625.2011.01261.x.

Article  PubMed  Google Scholar 

Scher JU, Ogdie A, Merola JF, Ritchlin C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol. 2019;15:153–66. https://doi.org/10.1038/s41584-019-0175-0.

Article  PubMed  Google Scholar 

Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005. https://doi.org/10.1001/archderm.141.12.1527.

Article  PubMed  Google Scholar 

Kaye JA, Li L, Jick SS. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol. 2008;159:895–902. https://doi.org/10.1111/j.1365-2133.2008.08707.x.

Article  PubMed  Google Scholar 

Kumthekar A, Ogdie A. Obesity and psoriatic arthritis: a narrative review. Rheumatol Ther. 2020;7:447–56. https://doi.org/10.1007/s40744-020-00215-6.

Article  PubMed  PubMed Central  Google Scholar 

Ash ZR, Tinazzi I, Gallego CC, Kwok C, Wilson C, Goodfield M, et al. Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. Ann Rheum Dis. 2012;71(4):553–6. https://doi.org/10.1136/annrheumdis-2011-200478.

Article  PubMed  Google Scholar 

Van Mechelen M, Lories RJ. Microtrauma. Curr Opin Rheumatol. 2016;28(2):176–80. https://doi.org/10.1097/BOR.0000000000000254.

Article  PubMed  Google Scholar 

Russolillo A, Iervolino S, Peluso R, Lupoli R, Di Minno A, Pappone N, et al. Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management. Rheumatology. 2013;52:62–7. https://doi.org/10.1093/rheumatology/kes242.

Article  PubMed  Google Scholar 

Azuaga AB, Ramírez J, Cañete JD. Psoriatic arthritis: pathogenesis and targeted therapies. Int J Mol Sci. 2023;24(5):4901. https://doi.org/10.3390/ijms24054901.

Article  PubMed  PubMed Central  Google Scholar 

González-Muniesa P, Mártinez-González M-A, Hu FB, Després J-P, Matsuzawa Y, Loos RJF, et al. Obesity. Nat Rev Dis Primers. 2017;3(1):17034. https://doi.org/10.1038/nrdp.2017.34.

Article  PubMed  Google Scholar 

Kirichenko TV, Markina YV, Bogatyreva AI, Tolstik TV, Varaeva YR, Starodubova AV. The role of adipokines in inflammatory mechanisms of obesity. Int J Mol Sci. 2022;23(23):14982. https://doi.org/10.3390/ijms232314982.

Article  PubMed  PubMed Central  Google Scholar 

Guo J, Zhang H, Lin W, Lu L, Su J, Chen X. Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Ther. 2023;8(1):437. https://doi.org/10.1038/s41392-023-01655-6.

Article  PubMed  PubMed Central  Google Scholar 

Park C-S, Shastri N. The role of T cells in obesity-associated inflammation and metabolic disease. Immune Netw. 2022. https://doi.org/10.4110/in.2022.22.e13.

Article  PubMed  PubMed Central  Google Scholar 

Kamata M, Tada Y. Dendritic cells and macrophages in the pathogenesis of psoriasis. Front Immunol. 2022. https://doi.org/10.3389/fimmu.2022.941071.

Article  PubMed  PubMed Central  Google Scholar 

Mavropoulos A, Rigopoulou EI, Liaskos C, Bogdanos DP, Sakkas LI. The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis. Clin Dev Immunol. 2013;2013:1–8. https://doi.org/10.1155/2013/569751.

Article  Google Scholar 

Ahmed M, Gaffen SL. IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev. 2010;21:449–53. https://doi.org/10.1016/j.cytogfr.2010.10.005.

Article  PubMed  PubMed Central  Google Scholar 

Hwang J, Yoo JA, Yoon H, Han T, Yoon J, An S, et al. The role of leptin in the association between obesity and psoriasis. Biomol Ther (Seoul). 2021;29(1):11–21. https://doi.org/10.4062/biomolther.2020.054.